GSK’s new $32,500 asthma med costs at least 2X too much, U.S. pricing watchdog says

Carly Helfand

GlaxoSmithKline has a new drug that's tailored for patients with a specific type of severe . But according to a nonprofit body that evaluates drugs' prices against their clinical effectiveness, it far, far too .

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS